Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,594 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical characteristics of patients who developed hepatocellular carcinoma after hepatitis C virus eradication with interferon therapy: current status in Japan.
Sato A, Sata M, Ikeda K, Kumada T, Izumi N, Asahina Y, Osaki Y, Chayama K, Kaneko S, Sakai A, Onji M, Hiasa Y, Omura T, Ozeki I, Yokosuka O, Shiina S, Itsubo M, Nishiguchi S, Hirano K, Ide T, Sakisaka S, Yamasaki T, Hidaka I, Tanaka M, Kim SR, Ichida T. Sato A, et al. Among authors: kaneko s. Intern Med. 2013;52(24):2701-6. doi: 10.2169/internalmedicine.52.1180. Intern Med. 2013. PMID: 24334571 Free article.
Mechanisms of viral hepatitis induced liver injury.
Nakamoto Y, Kaneko S. Nakamoto Y, et al. Among authors: kaneko s. Curr Mol Med. 2003 Sep;3(6):537-44. doi: 10.2174/1566524033479591. Curr Mol Med. 2003. PMID: 14527085 Review.
[2' 5'-oligoadenylate synthetase (2-5AS)].
Kaneko S, Sakai A. Kaneko S, et al. Nihon Rinsho. 2004 Dec;62 Suppl 12:812-4. Nihon Rinsho. 2004. PMID: 15658457 Review. Japanese. No abstract available.
Timing of interferon therapy and sources of infection in patients with acute hepatitis C.
Ogata K, Ide T, Kumashiro R, Kumada H, Yotsuyanagi H, Okita K, Akahane Y, Kaneko S, Tsubouchi H, Tanaka E, Moriwaki H, Nishiguchi S, Kakumu S, Mizokami M, Iino S, Sata M. Ogata K, et al. Among authors: kaneko s. Hepatol Res. 2006 Jan;34(1):35-40. doi: 10.1016/j.hepres.2005.08.012. Epub 2005 Dec 15. Hepatol Res. 2006. PMID: 16359917
Pretreatment prediction of interferon-alfa efficacy in chronic hepatitis C patients.
Hayashida K, Daiba A, Sakai A, Tanaka T, Kaji K, Inaba N, Ando S, Kajiyama N, Terasaki H, Abe A, Ogasawara M, Kohara M, Harada M, Okanoue T, Ito S, Kaneko S. Hayashida K, et al. Among authors: kaneko s. Clin Gastroenterol Hepatol. 2005 Dec;3(12):1253-9. doi: 10.1016/s1542-3565(05)00412-x. Clin Gastroenterol Hepatol. 2005. PMID: 16361052
Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis C virus and its susceptibility to interferon.
Hiraga N, Imamura M, Tsuge M, Noguchi C, Takahashi S, Iwao E, Fujimoto Y, Abe H, Maekawa T, Ochi H, Tateno C, Yoshizato K, Sakai A, Sakai Y, Honda M, Kaneko S, Wakita T, Chayama K. Hiraga N, et al. Among authors: kaneko s. FEBS Lett. 2007 May 15;581(10):1983-7. doi: 10.1016/j.febslet.2007.04.021. Epub 2007 Apr 20. FEBS Lett. 2007. PMID: 17466983 Free article.
3,594 results